Back to Feed
ClinicalTrials.gov|Clinical Trial
Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)
Kang Stem Biotech Co., Ltd.
Abstract
Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study Status: ACTIVE_NOT_RECRUITING Conditions: Dermatitis, Atopic
Keywords
Dermatitis, Atopic